Carbimazole

Composition

The formulation Contains carbimazole as the active ingredient.

Indications

treatment of hyperthyroidism

Side effects

Nausea, vomiting, rash, and arthralgia. Serious side effects can include agranulocytosis and hepatotoxicity.

Precautions

Regular blood count monitoring, Use with caution in patients with liver impairment or a history of bone marrow suppression

Contraindications

Contraindicated in patients with known hypersensitivity to carbimazole or any component of the formulation, as well as in patients with aplastic anemia

Dosage and administration

typically divided into multiple doses throughout the day

Countries

UK, Ireland, India

Available Forms

Tablets

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai